TABLE OF CONTENTS
Volume 5, Issue 1 (October 2007)
Papers |
US Case Reports |
EU Case Report |
US Legal and Regulatory Update |
EU Legal and Regulatory Update |
Patent Focus |
Book Reviews
Editorial
Creating a workable biogenerics pathway for patients FREE
Kathleen Jaeger
J Generic Med 5: 1-3; doi:10.1057/palgrave.jgm.4950094
Papers
New US trade policy: A turning point? FREE
María Fabiana Jorge
J Generic Med 5: 5-8; advance online publication, August 14, 2007; doi:10.1057/palgrave.jgm.4950093
Data protection: The new IP Frontier — An overview of existing laws and regulations FREE
Dolores Cullen
J Generic Med 5: 9-25; advance online publication, July 24, 2007; doi:10.1057/palgrave.jgm.4950087
Maximising generic utilisation: The power of pharmacy benefit management FREE
David B Snow Jr.
J Generic Med 5: 27-38; doi:10.1057/palgrave.jgm.4950095
Attention API suppliers: Quality agreements are here to stay FREE
Todd Grant Gattoni and Stephen D Sayre
J Generic Med 5: 39-44; advance online publication, July 24, 2007; doi:10.1057/palgrave.jgm.4950084
In pursuit of distinction: The method of the non-proprietary name FREE
R John Fidelino
J Generic Med 5: 45-52; advance online publication, May 29, 2007; doi:10.1057/palgrave.jgm.4950079
US Case Reports
Pfizer v Apotex: What is the current standard of obviousness under 35 USC § 103? FREE
Frederick H Rein and Joseph B Crystal
J Generic Med 5: 53-64; advance online publication, August 14, 2007; doi:10.1057/palgrave.jgm.4950090
EU Case Report
UK high court revokes Escitalopram UK Patent; Validity of second medical use claims based on dosage regimes in the UK; Stay of proceedings in the UK courts pending EPO opposition proceedings FREE
Robert Stephen
J Generic Med 5: 65-69; advance online publication, July 17, 2007; doi:10.1057/palgrave.jgm.4950083
US Legal and Regulatory Update
What is obvious? FREE
Neil F Greenblum
J Generic Med 5: 71-77; advance online publication, July 31, 2007; doi:10.1057/palgrave.jgm.4950089
EU Legal and Regulatory Update
Parallel imports, trade marks and regulatory FREE
Richard Milchior and Jean Andre
J Generic Med 5: 79-84; advance online publication, July 24, 2007; doi:10.1057/palgrave.jgm.4950086
Patent Focus
Fluvastatin and Atorvastatin: A comparison of patent protection (Part 2) FREE
Leighton Howard
J Generic Med 5: 85-90; advance online publication, August 7, 2007; doi:10.1057/palgrave.jgm.4950092
Book Reviews
Fine Chemicals: The Industry and the Business FREE
Reviewed by Paolo Romagnoli
J Generic Med 5: 91-92; doi:10.1057/palgrave.jgm.4950082
